Skip to main content

Published locations for Preadmission antidiabetic drug use and mortality risk in COVID-19 patients with T2D

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Preadmission antidiabetic drug use and mortality risk in COVID-19 patients with T2D

User login

  • Reset your password
  • /content/preadmission-antidiabetic-drug-use-and-mortality-risk-covid-19-patients-t2d
  • /endocrinology/article/253706/diabetes/preadmission-antidiabetic-drug-use-and-mortality-risk-covid-19
  • /type-2-diabetes-icymi/article/253706/diabetes/preadmission-antidiabetic-drug-use-and-mortality-risk